TEVA Teva Pharmaceutical Industries

$37.09▲ +2.04% Healthcare Other
After hours $37.09▲ +0.00% Sep 11, 5:32 PM ET
Volume 2.85M Avg Volume (10D) 4.88M
Key Metrics & Fundamentals
Market Cap
$43.22B
P/E Ratio
61.8
Div Yield
–%
52W Range
18.21 - 38.37
% vs 50 MA
6.34%
% vs 200 MA
13.01%
RSI-14
55.9
MACD Histogram
-0.1600
Beta (1Y vs SPY)
0.73
Free Cash Flow
$307.00M
Gross Rev
$4.14B
Gross Profit
$2.15B
EBITDA
$379.00M
COGS
$1.99B
Operating Exp
$2.00B
Operating Income
$149.00M
EBIT
$149.00M
Pretax Income
-$455.00M
Net Income
-$576.00M
EPS (Diluted)
-0.49
Price & Volume History
Loading chart…
Recent News
Teva Pharmaceutical Prices $4.9 Billion Senior Notes Offering
MT Newswires · Sep 10, 2026 10:36 AM
Teva Announces Successful Pricing of $4.9 billion (Equivalent) Senior Notes
GlobeNewswire · Sep 10, 2026 10:04 AM
BridgeBio Pharma (BBIO) Down 10.7% Since Last Earnings Report: Can It Rebound?
Zacks · Sep 9, 2026 3:30 PM
Leerink Partners Initiates Coverage on Teva Pharmaceutical Industries With Outperform Rating, $45 Price Target
MT Newswires · Sep 9, 2026 11:43 AM
Ulcerative Colitis Market Outlook: 5 Late-Stage Drug Candidates to Watch | DelveInsight
GlobeNewswire · Sep 7, 2026 5:00 PM
Teva Announces Launch of Offering of Senior Notes
GlobeNewswire · Sep 7, 2026 7:53 AM
S&P Global Ratings Upgrades Teva Pharmaceutical to 'BBB-'
MT Newswires · Sep 4, 2026 5:02 PM
Teva (TEVA) Backed a Bid of Up to $125M in Cash Plus Assumed Liabilities for BioXcel’s Assets. Is Bankruptcy-Sale Risk Worth the At-Home Opportunity?
Insider Monkey · Sep 4, 2026 4:01 PM
S&P Global Ratings Upgrades Teva to BBB-, Marking Third Credit Rating Upgrade in Recent Months and Reflecting Strong Execution and Financial Discipline
GlobeNewswire · Sep 4, 2026 3:30 PM
Vaxcyte Names New Medical and Legal Chiefs Ahead of Key Phase 3 Data
MT Newswires · Sep 3, 2026 9:33 PM
Financial Overview - Income Statement Quarterly

See TEVA's money flow as a full page

Social Sentiment
Avg +0.02 · 15 posts
TradeEarningsDiscussionThank you TEVA 🙌🏽💸
r/wallstreetbets · Jul 29, 2026
The author expresses satisfaction with a profitable trade related to TEVA, indicating a positive sentiment.
positive +0.60
NewsDiscussionA month Into The USA's War On Iran, Indian Investors Are Down By nearly ₹5 lakh crore.
r/StockMarket · Mar 30, 2026
Damage to a Teva facility due to military exchanges is mentioned.
negative +0.30
NewsDiscussionIsraeli pharma giant Teva recalls more than half-a-million bottles of blood pressure drug over potential carcinogens
r/investing · Dec 11, 2025
The post discusses a significant recall issue and the stock's minimal reaction, indicating negative sentiment. The comments confirm expected behaviour.
negative -0.60
NewsDiscussionTeva recalls more than half-a-million bottles of blood pressure drug over potential carcinogens
r/wallstreetbets · Dec 11, 2025
The recall of a drug due to potential carcinogens is a significant negative event for the company.
negative -0.80
AI Memory Hardware, Pharma & Strategic Industries – Watchlist 2026
r/stocks · Nov 23, 2025
The post highlights positive aspects of Teva’s performance, suggesting a potential investment opportunity.
positive +0.60
Page 1 of 3 (15 total)
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙